Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 2/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.35 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1742023 | 0.99 | HTR2C (0.44) | HTR2COPRL1MAOBHRH1HRH4 | |
| SCHEMBL7439313 | 0.88 | MAOB (0.46) | HTR2CMAOBHRH1HRH4CXCR2 | |
| SCHEMBL8540798 | 0.87 | HTR2C (0.44) | HTR2CMAOBHRH1HRH4CXCR2 | |
| SCHEMBL7453648 | 0.84 | HTR2C (0.40) | HTR2CMAOBHRH1HRH4CXCR2 | |
| SCHEMBL8024707 | 0.84 | HTR2C (0.41) | HTR2CMAOBHRH1HRH4CXCR3 | |
| SCHEMBL7454616 | 0.83 | HTR2C (0.41) | HTR2CMAOBHRH1HRH4CXCR3 | |
| SCHEMBL8541203 | 0.82 | HTR2C (0.42) | HTR2CMAOBHRH1HRH4CXCR3 | |
| SCHEMBL8542783 | 0.82 | MAOB (0.42) | HTR2CMAOBHRH1HRH4CXCR3 | |
| SCHEMBL8543404 | 0.81 | FAAH (0.42) | HTR2CMAOBHRH1HRH4 | |
| SCHEMBL8541412 | 0.81 | HTR2C (0.39) | HTR2CMAOBHRH1HRH4CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0866704-B1 | USE OF 1-(2-NAPHTH-2-YLETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE FOR PREPARING DRUGS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SANOFI SYNTHELABO (FR) | 2001-04-11 | — | — | EP | claimed |
| EP-0950050-A1 | METHOD FOR THE CRYSTALLISATION OF A TETRAHYDOPYRIDIN DERIVATIVE AND RESULTING CRYSTALLINE FORMS | SANOFI-SYNTHELABO (FR) | 1999-10-20 | — | — | EP | claimed |
| EP-0866704-A1 | USE OF 1-(2-NAPHTH-2-YLETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE FOR PREPARING DRUGS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SANOFI (FR) | 1998-09-30 | — | — | EP | claimed |
| WO-1998028271-A1 | METHOD FOR THE CRYSTALLISATION OF A TETRAHYDOPYRIDIN DERIVATIVE AND RESULTING CRYSTALLINE FORMS | SANOFI (FR) | 1998-07-02 | — | — | WO | claimed |
| WO-1997015304-A1 | USE OF 1-(2-NAPHTH-2-YLETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE FOR PREPARING DRUGS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SANOFI (FR) | 1997-05-01 | — | — | WO | claimed |
| EP-0950051-B1 | MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE | SANOFI SYNTHELABO (FR) | 2003-09-17 | — | — | EP | disclosed |
| EP-1102586-A1 | USE OF GINKGO BILOBA EXTRACTS FOR PREPARING A MEDICINE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2001-05-30 | — | — | EP | disclosed |
| EP-1017385-A1 | USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 | SANOFI-SYNTHELABO (FR) | 2000-07-12 | — | — | EP | disclosed |
| WO-2000007592-A1 | USE OF GINKGO BILOBA EXTRACTS FOR PREPARING A MEDICINE FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2000-02-17 | — | — | WO | disclosed |
| EP-0979079-A1 | USE OF TETRAHYDROPYRIDINE DERIVATIVES TO PREPARE MEDICINES FOR TREATING DISEASES CAUSING DEMYELINATION | SANOFI-SYNTHELABO (FR) | 2000-02-16 | — | — | EP | disclosed |
| EP-0950051-A1 | MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE | SANOFI-SYNTHELABO (FR) | 1999-10-20 | — | — | EP | disclosed |
| EP-0950052-A1 | METHOD FOR PREPARING A TETRAHYDROPYRIDIN DERIVATIVE | SANOFI-SYNTHELABO (FR) | 1999-10-20 | — | — | EP | disclosed |
| WO-1998053821-A1 | USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1 | SANOFI-SYNTHELABO (FR) | 1998-12-03 | — | — | WO | disclosed |
| WO-1998048802-A1 | USE OF TETRAHYDROPYRIDINE DERIVATIVES TO PREPARE MEDICINES FOR TREATING DISEASES CAUSING DEMYELINATION | SANOFI-SYNTHELABO (FR) | 1998-11-05 | — | — | WO | disclosed |
| EP-0866704-A1 | USE OF 1-(2-NAPHTH-2-YLETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE FOR PREPARING DRUGS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SANOFI (FR) | 1998-09-30 | — | — | EP | disclosed |
| WO-1998028273-A1 | METHOD FOR PREPARING A TETRAHYDROPYRIDIN DERIVATIVE | SANOFI (FR) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998028272-A1 | MICRO-PARTICULATE FORM OF A TETRAHYDROPYRIDIN DERIVATIVE | SANOFI (FR) | 1998-07-02 | — | — | WO | disclosed |
| WO-1997015304-A1 | USE OF 1-(2-NAPHTH-2-YLETHYL)-4-(3-TRIFLUOROMETHYLPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE FOR PREPARING DRUGS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | SANOFI (FR) | 1997-05-01 | — | — | WO | disclosed |
| US-5026716-A | Method of treatment of anxiety and anxio-depressive disorders | SANOFI (FR) | 1991-06-25 | — | — | US | disclosed |